Therapeutic experience of severe and recurrent secondary hyperparathyroidism in a patient on hemodialysis for 18 years: A case report

Medicine
Mingwen ZhuLijie Pan

Abstract

For patients with refractory secondary hyperparathyroidism (SHPT), parathyroidectomy (PTX) has received increasing attention. However, evidence-based medicine shows that there is still controversy regarding surgical methods, efficacy, and safety. We retrospectively analyzed the process of diagnosis and treatment in one patient with severe SHPT and long-term chronic renal failure (CRF), so as to further improve the therapeutic effect. A 61-year-old female with SHPT and CRF manifested as no urine for 18 years, underwent PTX 4 times since September 2010, with satisfactory final recovery. The first operation involved resection of 3 parathyroid glands in the normal position; the second operation involved removal of an ectopic parathyroid gland, combined with parathyroid gland autotransplantation; the third operation was performed to resect suspected recurrent parathyroid gland; the fourth operation involved partial excision of the autotransplanted parathyroid glands. Accurate preoperative localized diagnosis and optimal surgical approach play key roles in the prevention and treatment of SHPT; postoperative recurrence of SHPT caused by ectopic or autotransplanted parathyroid gland should receive more attention.

References

May 8, 2004·American Journal of Physiology. Renal Physiology·Randolph A Chen, William G Goodman
Jul 11, 2006·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Pablo Ureña Torres
Feb 28, 2009·World Journal of Surgery·Yoshihiro TominagaNobuaki Uno
Aug 9, 2011·The Journal of International Medical Research·J NarandaB Pečovnik-Balon
Oct 13, 2011·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Ayman AghaMarcus N Scherer
Dec 18, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Francesca TentoriBruce M Robinson
May 8, 2015·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Xiaoyan JiaDongmei Xu
Aug 22, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·James B WetmoreAllan J Collins
Nov 1, 2016·Langenbeck's Archives of Surgery·Aleksander KonturekWojciech Nowak
Jul 28, 2016·Annals of Surgical Oncology·Willemijn Y van der PlasSchelto Kruijff
Dec 17, 2016·The Journal of Surgical Research·Melissa LoPintoJohn I Lew
Jan 4, 2017·Clinical and Experimental Nephrology·Hirotaka KomabaMasafumi Fukagawa
Feb 23, 2017·International Journal of Nephrology and Renovascular Disease·Pongsathorn GojaseniAnutra Chittinandana

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.